Horizon Therapeutics USA, INC. (Formerly Horizon Pharma USA, INC.)
Biopharmaceutical Development
Based in IL
🤖
AI Overview
With $1.5M in lobbying spend across 22 quarterly filings, Horizon Therapeutics USA, INC. (Formerly Horizon Pharma USA, INC.) is a significant lobbying presence.
$1.5M
Total Lobbying Spend
22
Quarterly Filings
1
Lobbying Firms Used
6
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $220K |
| 2019 | $280K |
| 2020 | $240K |
| 2021 | $250K |
| 2022 | $240K |
| 2023 | $240K |
Lobbying Firms
COVINGTON & BURLING LLP
What They Lobby For
- Medicare reimbursement issue; 340B reform.
- Tax reform.
- Medicare reimbursement issue; orphan drug program.
- Orphan drug tax issues.
- Tax issues under the CARES Act.
- Medicare coverage of home infusion drugs.
- Medicare drug pricing reform.
- Tax issues.
- Drug pricing policies.
- 340B policy.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.